ArrePath

ArrePath is a biotechnology company based in Princeton, New Jersey, focused on anti-infective drug discovery.

Founded in 2021, the company aims to combat antimicrobial resistance (AMR) through its proprietary AI/ML-powered drug discovery platform. This platform combines human intelligence with advanced machine learning and imaging technologies to identify novel compounds and optimize drug development. The company is developing a range of small molecule therapeutics, including anti-infective agents targeting drug-resistant Gram-negative bacteria and novel antibiotics. ArrePath's innovative approach addresses critical healthcare challenges by providing solutions for infections that current treatments struggle to manage. With a commitment to advancing its pipeline and technology, ArrePath is positioned to make significant contributions to the field of infectious disease treatment.